Filing Details

Accession Number:
0001209191-19-000918
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-03 16:19:16
Reporting Period:
2018-12-31
Accepted Time:
2019-01-03 16:19:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365369 F John Sheridan C/O Tandem Diabetes Care, Inc.,
11075 Roselle Street
San Diego CA 92121
Evp, Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-31 788 $37.81 666 No 4 S Direct
Common Stock Acquisiton 2019-01-02 20,000 $2.59 20,666 No 4 M Direct
Common Stock Disposition 2019-01-02 4,599 $36.23 16,067 No 4 S Direct
Common Stock Disposition 2019-01-02 15,401 $35.51 666 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-01-02 20,000 $0.00 20,000 $2.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,000 2027-12-01 No 4 M Direct
Footnotes
  1. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.75 and $37.85.
  2. Represents shares of common stock received upon exercise of a stock option award.
  3. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $36.04 and $36.55.
  4. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $35.02 and $35.87.
  5. Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter